GSK

GSK

Signal active

Investment Firm

Overview

GSK is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Their products are used by millions of people around the world, helping them to do more, feel better and live longer.

Highlights

Founded

2000

Industry

Venture Capital

Employees

10001+

Investment

17

Lead Investment

2

Exits

5

Stages

Late Stage Venture, Early Stage Venture, Seed

Investor Type

Venture Capital

Location

Kelayres, Pennsylvania, United States, North America

Contact Information

Social

Profile Resume

GSK, established in 2000 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed investments across Biotechnology, Health Care, Pharmaceutical, Medical, Venture Capital, Finance, Business Development, Photography, Angel Investment, Financial Services. The organization boasts a portfolio of 17 investments, with an average round size of $23.3M and 5 successful exits. Their recent investments include Concert Pharmaceuticals, Flagship Pioneering, Brookside Capital, Skyline Ventures, Three Arch Partners. The highest investment round they participated in was $31.8B. Among their most notable exits are Concert Pharmaceuticals and Flagship Pioneering. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Mehdi El Gueddari

Mehdi El Gueddari

Principal Software Engineer

imagePlace Maxine Razavi

Maxine Razavi

Agile Team Coach/Scrum Master

imagePlace Judy Lewent

Judy Lewent

Non-Executive Director

imagePlace Tom de Swaan

Tom de Swaan

Independent Non-Executive Director

imagePlace Simon Bicknell

Simon Bicknell

Senior Vice President, Governance, Ethics and Assurance

imagePlace Roger Connor

Roger Connor

President, Global Manufacturing & Supply

Investment portfolio

GSK has made 17 investments. Their most recent investment was on May 14, 2024, when Elegen raised $35.0M.

GSK has made 7 diversity investments. Their most recent diversity investment was on Apr 05, 2023, when Patientory raised $1.5M.

investments

17

Diversity investments

7

Lead investments

2

Number of exits

5

Investments

17

Annouced DateOrganization NameIndustryMoney Raised
Apr 05, 2023
Patientory Patientory
Software1.5M
Sep 27, 2023--39.0M
May 07, 2024--13.5M
May 14, 2024
Elegen Elegen
Biotechnology35.0M

Exits

5

Funding Timeline

Funding rounds

17

Investors

0

Funds

0

Funding Rounds

17

GSK has raised 17 rounds. Their latest funding was raised on May 14, 2024 from a Series B - Elegen round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Apr 05, 2023
Seed Round - Patientory Seed Round - Patientory
-1.5M-
Sep 27, 2023
Series A - Sitryx Therapeutics Series A - Sitryx Therapeutics
-39.0M-
May 07, 2024
Series C - BioVersys Series C - BioVersys
-13.5M-
May 14, 2024
Series B - Elegen Series B - Elegen
-35.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries